Moneyta · stock research · no sign-up needed
MCK
FollowFigures below come straight from SEC filings: every number is the company's own, on the record.
Revenue (Q1 FY2027)
$105.4B
+16.0% y/y
Net income (Q1 FY2027)
$614M
as filed with the SEC
Institutions holding
2,025
-27 last quarter
Overview · MCKESSON CORP
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also…
Management team
- Paul A. Smith · Senior Vice President of TaxesFind on LinkedIn
- Ms. Rachel Rodriguez · Vice President of Investor RelationsFind on LinkedIn
- Ms. Michele Lau J.D. · Executive VP & Chief Legal OfficerFind on LinkedIn
- Mr. Britt J. Vitalone CPA · Executive VP & CFOFind on LinkedIn
Start free to see the full management team.
Links open LinkedIn searches, not verified profiles. Team data from our market-data vendor's company profile.
What history says when its signals fire
Every signal Moneyta surfaces carries its full base-rate history: how often it beat the index, and how often it didn't. See the evidence
The desk's Snapshot
3 of 15 open to everyone · members see allRead the full desk report on MCK
Seven analysts, the debate, the risk review, every claim cited. And the same for every name you hold.
Free plan, no credit card required. Silver opens the full report, $19.99 a month. AI-written · every claim cites a source · Insight, not advice.
The full desk report
Seven AI analysts read the filings and argue both sides. What survives, with every claim cited, for members.
Who holds it, who's buying Gold
Full holder table, quarter-over-quarter flows, insider transactions, and the conviction screen.
Largest holder
Net flow last quarter
Insider buys, 90d
Further reading
Source: SEC EDGAR (XBRL company facts, form 13F-HR). Educational analysis of published data: insight, not advice.